Loading

The State of Emerging Biotechs: Investment, Deal, and Pipeline Trends

June 04, 2024
Special Program
Business Development and Finance
32AB
Chad Wessel, BIO’s Director of Industry Research, will provide an overview of recent investment and deal trends for emerging therapeutic companies, as well as an update on the R&D pipeline and recent FDA approvals. The BIO Industry Analysis team publishes quarterly interactive data on licensing, M&A, venture capital, IPOs, follow-on public offerings, and FDA approvals at www.bio.org/iareports.
Speakers
Chad Wessel
Director, Industry Analysis
Biotechnology Innovation Organization (BIO)
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS